Anebulo Pharmaceuticals (ANEB) Earnings Date & Reports
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
ANEB is expected to report earnings to rise 140.00% to -11 cents per share on November 07
Q3'25
Est.
$-0.12
Q2'25
Est.
$-0.05
Q1'25
Beat
by $0.04
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.03
The last earnings report on September 29 showed earnings per share of -5 cents, meeting the estimate of -5 cents. With 23.36K shares outstanding, the current market capitalization sits at 103.53M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANEB showed earnings on September 29, 2025. You can read more about the earnings report here.